EdgeScore

AMIX · Nasdaq

Autonomix Medical, Inc.: financial statements

Insufficient data · see the checkFigures in USD, fiscal years

Revenue and net income

Revenue 2023: $0Net income 2023: -$2.0M2023Revenue 2024: $0Net income 2024: -$15.4M2024Revenue 2025: $0Net income 2025: -$11.4M2025Revenue 2026: $0Net income 2026: -$16.7M2026
RevenueNet income

Operating and free cash flow

Operating cash flow 2023: -$1.9MFree cash flow 2023: -$1.9M2023Operating cash flow 2024: -$6.6MFree cash flow 2024: -$6.6M2024Operating cash flow 2025: -$8.3MFree cash flow 2025: -$8.3M2025Operating cash flow 2026: -$12.3MFree cash flow 2026: -$12.3M2026
Operating cash flowFree cash flow

Returns

ROE 2023: -309.0%ROE 2024: -202.2%ROE 2025: -140.9%ROE 2026: -283.5%ROA 2023: -230.1%ROA 2024: -164.0%ROA 2025: -116.4%ROA 2026: -219.9%2023202420252026
ROEROICROA

Income statement

USD2023202420252026Last year
Revenue$0$0$0$0
Operating income-$2.0M-$12.0M-$11.6M-$17.0M-47%
EBITDA-$2.0M-$11.9M-$11.4M-$17.0M-49%
Interest expense$0$79.0K$176K$0-100%
Profit before tax-$2.0M-$15.4M-$11.4M-$16.7M-46%
Income tax$0$0$0$0
Net income-$2.0M-$15.4M-$11.4M-$16.7M-46%

Cash flow

USD2023202420252026Last year
Operating cash flow-$1.9M-$6.6M-$8.3M-$12.3M-49%
Capital expenditure$0$19.0K$14.0K$10.0K-29%
Free cash flow-$1.9M-$6.6M-$8.3M-$12.3M-49%
Depreciation & amortization$0$81.0K$183K$12.0K-93%

Balance sheet

USD2023202420252026Last year
Cash$865K$8.6M$9.1M$7.0M-23%
Current assets$865K$9.4M$9.6M$7.6M-21%
Total assets$865K$9.4M$9.8M$7.6M-22%
Current liabilities$221K$777K$1.7M$1.7M-0%
Total liabilities$221K$1.8M$1.7M$1.7M-0%
Shareholders' equity$644K$7.6M$8.1M$5.9M-27%
Net debt-$865K-$8.6M-$9.1M-$7.0M+23%

Ratios

2023202420252026Last year
Return on equity-309.0%-202.2%-140.9%-283.5%
Return on assets-230.1%-164.0%-116.4%-219.9%
Interest coverage—-152.3x-65.8x—
Current ratio3.9112.095.634.45
Quick ratio3.9112.095.634.45

Data source: SEC EDGAR, company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.